Research Institute for Medicines and Pharmaceutical Sciences (iMedUL), Faculty of Pharmacy, University of Lisbon, Lisbon, Portugal.
Neurochem Int. 2012 Jan;60(2):192-8. doi: 10.1016/j.neuint.2011.12.003. Epub 2011 Dec 13.
Cholesterol metabolism in the brain is distinct from that in other tissues due to the fact that cholesterol itself is unable to pass across the blood-brain barrier. Elimination of brain cholesterol is mainly dependent on a neuronal-specific cytochrome P450, CYP46A1, catalyzing the conversion of cholesterol into 24(S)-hydroxycholesterol (24OHC), which is able to pass the blood-brain barrier. A suitable model for studying this elimination from human neuronal cells has not been described previously. It is shown here that differentiated Ntera2/clone D1 (NT2) cells express the key genes involved in brain cholesterol homeostasis including CYP46A1, and that the expression profiles of the genes observed during neuronal differentiation are those expected to occur in vivo. Thus there was a decrease in the mRNA levels corresponding to cholesterol synthesis enzymes and a marked increase in the mRNA level of CYP46A1. The latter increase was associated with increased levels of CYP46A1 protein and increased production of 24OHC. The magnitude of the secretion of 24OHC from the differentiated NT2 cells into the medium was similar to that expected to occur under in vivo conditions. An alternative to elimination of cholesterol by the CYP46A1 mechanism is elimination by CYP27A1, and the product of this enzyme, 27-hydroxycholesterol (27OHC), is also known to pass the blood-brain barrier. The CYP27A1 protein level decreased during the differentiation of the NT2 cells in parallel with decreased production of 27OHC. The ratio between 24OHC and 27OHC in the medium from the cultured cells increased, by a factor of 13, during the differentiation process. The results suggest that progenitor cells eliminate cholesterol in the form of 27OHC while neurogenesis induces a change to the CYP46A1 dependent pathway. Furthermore this study demonstrates that differentiated NT2 cells are suitable for studies of cholesterol homeostasis in human neurons.
脑内的胆固醇代谢与其他组织不同,因为胆固醇本身无法穿过血脑屏障。脑内胆固醇的清除主要依赖于神经元特异性细胞色素 P450(CYP46A1),该酶将胆固醇转化为 24(S)-羟基胆固醇(24OHC),后者可以穿过血脑屏障。之前尚未描述过用于研究从人神经元细胞中清除胆固醇的合适模型。本文显示分化的 Ntera2/clone D1(NT2)细胞表达参与脑胆固醇稳态的关键基因,包括 CYP46A1,并且在神经元分化过程中观察到的基因表达谱与体内预期的表达谱一致。因此,胆固醇合成酶的 mRNA 水平降低,而 CYP46A1 的 mRNA 水平显著增加。后者的增加与 CYP46A1 蛋白水平的升高以及 24OHC 的产量增加有关。分化的 NT2 细胞向培养基中分泌的 24OHC 量与体内条件下预期的量相似。CYP46A1 机制消除胆固醇的替代方法是通过 CYP27A1 消除,该酶的产物 27-羟基胆固醇(27OHC)也已知可以穿过血脑屏障。随着 NT2 细胞的分化,CYP27A1 蛋白水平降低,同时 27OHC 的产量降低。培养细胞培养基中 24OHC 和 27OHC 的比例在分化过程中增加了 13 倍。结果表明,祖细胞以 27OHC 的形式消除胆固醇,而神经发生诱导了 CYP46A1 依赖性途径的改变。此外,本研究表明分化的 NT2 细胞适合用于研究人神经元中的胆固醇稳态。